Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Arun Kumar Singh
Édition Anoop Kumar , Neeraj Mishra
Passer aux renseignements sur les produits

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Arun Kumar Singh
Édition Anoop Kumar , Neeraj Mishra
Date de sortie :
Couverture souple
Prix habituel $266.50
Prix promotionnel $266.50 Prix habituel $0.00
Vente ferme. Aucun retour ni échange.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.

Téléchargement numérique

Accès immédiat à votre bibliothèque Kobo

Livrer à

Arrive le

Acheter maintenant et ramasser en magasin Bay & Floor

Ramassage gratuit aujourd’hui

Trouver en magasin

En rupture de stock

Trouvé dans : Health, Medical Reference

Obtenez 1333 points plum  et profitez d’un rabais additionnel avec plum. En savoir plus

Afficher tous les renseignements

Aperçu

440 PAGESANGLAIS

Info promotionnelle
  • Date de publication : Nov 01, 2026
  • Langue : anglais
  • Nombre de pages : 440
  • Éditeur : Academic Press Incorporated
  • ISBN : 9780443341410
  • Dimensions : 7.5" W x 1.0" L x 9.25" H

Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.

Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications inBiochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.



Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has extensive teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for cancer and neurodegenerative disorders. His research interests focus on advanced pharmaceutical formulations and controlled delivery approaches aimed at improving therapeutic outcomes.

Dr. Mishra has supervised postgraduate and doctoral research scholars and has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He is also associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, research, and pharmaceutical education. He has additionally been recognized internationally for his research impact and scholarly contributions in the field of pharmaceutical sciences.



Dr. Anoop Kumar is an Assistant Professor in the Department of Pharmacology at Delhi Pharmaceutical Sciences & Research University (DPSRU), India. With a distinguished career, he has previously served as an Assistant Professor and Head at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and as Head and Associate Professor at ISF College of Pharmacy, Moga, Punjab. Dr. Kumar has also held research positions at Sun Pharmaceutical Industries Limited and Translational Health Science Institute (THSTI). He earned his Ph.D. from Birla Institute of Technology, Mesra, Ranchi, as a DST INSPIRE Fellow. He is an Associate Editor for Health Sciences Review and Acta Neurologica Scandinavica. His research focuses on drug repurposing, clinical trial meta-analysis, pharmacoeconomics, and pharmacovigilance.



Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World's Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.

Articles récemment consultés